当前位置：
X-MOL 学术
›
J. Clin. Invest.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure.
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2020-03-16 , DOI: 10.1172/jci130197 Daxian Wu 1, 2 , Sainan Zhang 1 , Zhongyang Xie 1 , Ermei Chen 1 , Qunfang Rao 1 , Xiaoli Liu 1 , Kaizhou Huang 1 , Jing Yang 1 , Lanlan Xiao 1 , Feiyang Ji 1 , Zhengyi Jiang 1 , Yalei Zhao 1 , Xiaoxi Ouyang 1 , Danhua Zhu 1 , Xiahong Dai 3 , Zhouhua Hou 4 , Bingjie Liu 5 , Binbin Deng 4 , Ning Zhou 6 , Hainv Gao 3 , Zeyu Sun 1 , Lanjuan Li 1
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2020-03-16 , DOI: 10.1172/jci130197 Daxian Wu 1, 2 , Sainan Zhang 1 , Zhongyang Xie 1 , Ermei Chen 1 , Qunfang Rao 1 , Xiaoli Liu 1 , Kaizhou Huang 1 , Jing Yang 1 , Lanlan Xiao 1 , Feiyang Ji 1 , Zhengyi Jiang 1 , Yalei Zhao 1 , Xiaoxi Ouyang 1 , Danhua Zhu 1 , Xiahong Dai 3 , Zhouhua Hou 4 , Bingjie Liu 5 , Binbin Deng 4 , Ning Zhou 6 , Hainv Gao 3 , Zeyu Sun 1 , Lanjuan Li 1
Affiliation
BACKGROUND. HBV-related acute-on-chronic liver failure (HBV-ACLF) is hallmarked by high short-term mortality rates, calling for accurate prognostic biomarkers for initial risk stratification.
中文翻译：
纤溶酶原作为HBV相关的慢性慢性肝衰竭的预后生物标志物。
背景。HBV相关的慢性慢性肝衰竭（HBV-ACLF）的特点是短期死亡率高，因此需要准确的预后生物标志物以进行初始风险分层。
更新日期：2020-04-03
中文翻译：
纤溶酶原作为HBV相关的慢性慢性肝衰竭的预后生物标志物。
背景。HBV相关的慢性慢性肝衰竭（HBV-ACLF）的特点是短期死亡率高，因此需要准确的预后生物标志物以进行初始风险分层。
京公网安备 11010802027423号